Related Experiment Video
Updated: Jul 6, 2026
07:44
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Gene delivery to dystrophic muscle
Kim E Wells1, Jill McMahon, Helen Foster
1Department of Cellular and Molecular Neuroscience, Division of Neuroscience and Mental Health, Imperial College, London, United Kingdom.
Methods in Molecular Biology (Clifton, N.J.)
|March 29, 2008
Summary
Electroporation effectively delivers genes to dystrophic muscle in mice, but efficiency decreases with larger DNA. This method is valuable for studying gene transfer immune responses without viral vectors.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Genetics
Background:
- Duchenne muscular dystrophy (DMD) is a genetic disorder affecting muscle.
- Gene therapy is a potential treatment strategy for DMD.
- Electroporation offers a non-viral method for gene delivery.
Purpose of the Study:
- To evaluate electroporation for gene delivery in the mdx mouse model of DMD.
- To assess the impact of plasmid size on gene transfer efficiency.
- To explore electroporation as a tool for studying immune responses to gene transfer.
Main Methods:
- Utilizing electroporation for gene delivery in dystrophic mouse muscle.
- Administering reporter plasmids, therapeutic plasmids, and antisense oligonucleotides.
- Analyzing gene transfer efficiency based on plasmid size.
Main Results:
- Successful transfer of genetic material (plasmids, oligonucleotides) was achieved.
- Gene transfer efficiency diminished as plasmid size increased.
- Electroporation demonstrated utility in assessing immune responses independent of vector proteins.
Conclusions:
- Electroporation is a viable, albeit size-limited, method for gene delivery in the mdx mouse model.
- This technique serves as a crucial experimental tool for investigating gene transfer immunogenicity.
- Clinical utility may be limited, but its research applications are significant.
More Related Videos
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...